However, we currently have very little data on how much of these medicines pass into breastmilk, or whether they cause side effects in breastfed children
In this article Key Takeaways CJC-1295 and Ipamorelin are not FDA-approved drug products
He CC, Klionsky DJ
Competitive landscape: Strong efficacy positions aleniglipron as a potential challenger to programs from Novo Nordisk and Eli Lilly in the oral incretin space
Before making any changes to your GLP-1 medication management, consider these factors: Current treatment response: If your injectable medication is working well, switching may not offer additional benefits Lifestyle compatibility: The empty stomach requirement and 30-minute waiting period requires consistent daily scheduling Cost considerations: Insurance coverage for the pill may differ from injectable coverage initially Other medications: The timing restrictions may complicate existing medication schedules Optimizing Your Results: Beyond the Medication Whether you choose oral or injectable GLP-1 treatment, medication alone isnt the complete picture
References Abdul Basith Khan, M., Hashim, M., Kwan king, J., Devi Govender, R., Mustafa, H., & Al Kaabi, J